Pfizer announced Sunday that it was making major leadership changes in the areas of research and finance.
John LaMattina, the longtime president of global research and development, will retire from the company by the end of the year, Pfizer said.
The company's chief financial officer, Alan Levin, also resigned, the company said.
Source
John LaMattina, the longtime president of global research and development, will retire from the company by the end of the year, Pfizer said.
The company's chief financial officer, Alan Levin, also resigned, the company said.
Source
Can't wait to hear what Peter Rost has to say about this!
Where were the newspaper journalists?
Score another one for the bloggers.
No comments:
Post a Comment